Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence [Phase 2]
Phase 2 trial of Vitespen (HSPPC-96, Oncophage) for immune response in resectable renal cell carcinoma at intermediate risk of recurrence; s…
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued. [Phase 2]
A Phase 2 rollover study of tremelimumab for patients who had received it in other protocols, to provide continued access until it becomes c…
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Study of Dalantercept and Axitinib in Patients With Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial of dalantercept in combination with axitinib for advanced renal cell carcinoma was terminated; results posted in 2021…
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy
Retrospective study update on referral patterns for high-risk patients after nephrectomy in renal cell carcinoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. [Phase 1]
Phase 1 safety study assessing cG250 antibody labeled with 124-Iodine for diagnosing renal masses has been completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer [Phase 2]
A Phase II trial of the DNA methyltransferase inhibitor guadecitabine (SGI-110) in children and adults with wild-type GIST, paraganglioma, p…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating a biomarker-driven strategy with nivolumab plus ipilimumab or VEGFR TKI in first-line clear cell metastatic renal c…
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: A Study of CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinoma [Phase 2]
Phase 2 trial update for CaBozantinib in metastatic/metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating sorafenib with gemcitabine and capecitabine in unresectable or metastatic renal cell carcinoma; results posted af…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer [Phase 1, Phase 2]
Phase 1/2 study of sacituzumab govitecan-hziy (IMMU-132) in adults with epithelial cancers; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments
A completed clinical trial assessing outcomes for metastatic renal cell carcinoma patients who received sunitinib after first-line immune-on…
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: SBRT (Stereotactic Body Radiation Therapy) in Combination With Nivolumab/Ipilimumab in Renal Cell Carcinoma (RCC) / Kidney Cancer Patients [Phase 2]
Phase 2 trial evaluating SBRT with nivolumab/ipilimumab in metastatic/Stage IV kidney cancer has completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Brivanib Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial update for brivanib in metastatic renal cell carcinoma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma [Phase 2]
Phase 2 study evaluating safety and efficacy of lenvatinib (18 mg vs 14 mg) in combination with everolimus for renal cell carcinoma has comp…
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma [Phase 2]
Phase 2 biomarker trial of everolimus in advanced renal cell carcinoma has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer [Phase 1, Phase 2]
Phase 1/2 trial of entinostat in combination with aldesleukin for renal cell carcinoma, with results posted and the study listed as active/n…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial comparing MLN0128 (and MLN0128 + MLN1117) vs everolimus in adults with advanced or metastatic clear-cell renal cell carcinoma;…
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: CM082 Combined With Everolimus in Chinese Patients With Metastatic Renal Cell Carcinoma [Phase 3]
A Phase 3 trial evaluating CM082 in combination with everolimus in Chinese patients with metastatic renal cell carcinoma is currently status…
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial studying vandetanib combined with metformin in patients with hereditary leiomyomatosis-related renal cell carcinoma (HLRCC…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: the Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors [Phase 2]
Phase 2 trial assessing efficacy and safety of LDP in patients with bladder cancer, renal carcinoma, and advanced penile carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating cabozantinib as subsequent therapy after an immune checkpoint-based treatment in renal cell carcinoma is underway, …
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating avelumab plus intermittent axitinib in previously untreated metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment. [Phase 2]
Phase 2 trial update evaluating nivolumab and ipilimumab in patients with T1aN0M0 renal cell carcinoma ineligible for surgery.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating emibetuzumab in combination with ramucirumab in various advanced cancers, with completed status and results poste…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing [Phase 2]
Phase 2 trial evaluating an alternative dosing schedule of sunitinib in metastatic renal cell carcinoma, using cardiopulmonary exercise test…